Skip to main content
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.560
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.600
+0.040 (0.88%)
After-hours: Apr 28, 2026, 7:56 PM EDT

Nuvation Bio Revenue

In the year 2025, Nuvation Bio had annual revenue of $62.90M with 698.96% growth. Nuvation Bio had revenue of $41.87M in the quarter ending December 31, 2025, with 633.06% growth.

Revenue (ttm)
$62.90M
Revenue Growth
+698.96%
P/S Ratio
25.21
Revenue / Employee
$211,081
Employees
298
Market Cap
1.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202562.90M55.03M698.96%
Dec 31, 20247.87M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 868.45M
Innoviva 411.33M
AnaptysBio 234.60M
Nurix Therapeutics 71.78M
Vir Biotechnology 68.56M
Intellia Therapeutics 67.67M
Generate Biomedicines 31.89M
AtaiBeckley 4.09M
Revenue Rankings

NUVB News

More News